Stock 600513 JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Equities

600513

CNE000001DP6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 19/06/2024 am IST 		5-day change 1st Jan Change
8.21 CNY -0.61% Intraday chart for Jiangsu Lianhuan Pharmaceutical Co., Ltd. -3.18% -26.30%
02:32pm China Grants Active Pharmaceutical Ingredient Marketing Approval for Lianhuan Pharma's Cardiac Treatment MT
05/06 China Approves Lianhuan Pharma's Prostate Cancer Tablets MT

Business Summary

Jiangsu Lianhuan Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, production and sales of chemical medicines. The Company's products are mainly applied as urinary system medicines, antihistamines and cardiovascular medicines. The Company's products include Epristeride Tablets, Ebastine Tablets, Felodipine Tablets, Felodipine Sustained Release Capsules, Simvastatin Tablets, Lumbrokinase Capsulesand and Balofloxacin Tablets. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 1,296

Sales per Business

CNY in Million2022Weight2023Weight Delta
Tablet
49.6 %
1,080 55.3 % 1,078 49.6 % -0.25%
Medical Device
24.3 %
378 19.3 % 529 24.3 % +39.94%
API
12.7 %
230 11.7 % 276 12.7 % +20.33%
Other
8.0 %
150 7.7 % 175 8.0 % +16.52%
Injection
4.4 %
101 5.2 % 95 4.4 % -6.31%
Other Business
1.0 %
16 0.8 % 21 1.0 % +34.37%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.3 %
1,901 98.0 % 2,115 98.3 % +11.25%
International
1.7 %
38 2.0 % 37 1.7 % -1.21%

Managers

Managers TitleAgeSince
Ben Niu CEO
 Chief Executive Officer 43 22/20/22
Wen Ge Wu CHM
 Chairman 56 17/14/17
He Ping Pan DFI
 Director of Finance/CFO 60 19/09/19
Bao Chang Yu BRD
 Director/Board Member 40 01/12/01
Wen Tao Huang SEC
 Corporate Secretary 35 01/18/01

Members of the board

Members of the board TitleAgeSince
He Ping Pan DFI
 Director of Finance/CFO 60 19/09/19
Bin Zhang BRD
 Director/Board Member 56 22/20/22
Guang Ji Wang BRD
 Director/Board Member 71 22/18/22
Ying Chen BRD
 Director/Board Member 47 01/19/01
Wen Ge Wu CHM
 Chairman 56 17/14/17
Zhen Hua Qian CHM
 Chairman 53 -
Bao Chang Yu BRD
 Director/Board Member 40 01/12/01
Chun Lai Xia BRD
 Director/Board Member 50 01/16/01
Ying Chen
47 -
Jing Zhang BRD
 Director/Board Member 35 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 285,456,270 164,213,617 ( 57.53 %) 0 57.53 %

Shareholders

NameEquities%Valuation
Taiping Fund Management Co., Ltd.
0.0844 %
241,000 0.0844 % 293 432 ¥
Shanghai Guotai Junan Securities Assets Management Co., Ltd.
0.0134 %
38,300 0.0134 % 46 633 ¥
China Southern Asset Management Co., Ltd.
0.0106 %
30,400 0.0106 % 37 014 ¥
Fullgoal Fund Management Co., Ltd.
0.008968 %
25,600 0.008968 % 31 170 ¥
ABC-CA Fund Management Co., Ltd.
0.005640 %
16,100 0.005640 % 19 603 ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.003643 %
10,400 0.003643 % 12 663 ¥
China Asset Management Co., Ltd.
0.003223 %
9,200 0.003223 % 11 202 ¥
Guotai Asset Management Co., Ltd.
0.000315 %
900 0.000315 % 1 096 ¥

Company contact information

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Bio-Health Industrial Park 9, Jianjing 1st Road

225127, Yangzhou

+

http://www.lhpharma.com
address Jiangsu Lianhuan Pharmaceutical Co., Ltd.(600513)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD. Stock Jiangsu Lianhuan Pharmaceutical Co., Ltd.
-26.30% 323M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+53.97% 803B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.12% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.23% 324B
ABBVIE INC. Stock AbbVie Inc.
+10.72% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.74% 243B
ROCHE HOLDING AG Stock Roche Holding AG
+2.25% 228B
NOVARTIS AG Stock Novartis AG
+10.97% 217B
AMGEN INC. Stock Amgen Inc.
+6.11% 164B
PFIZER, INC. Stock Pfizer, Inc.
-4.15% 155B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600513 Stock
  4. Company Jiangsu Lianhuan Pharmaceutical Co., Ltd.